Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.39
+0.17 (3.16%)
Jul 16, 2025, 11:13 AM - Market open
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.34 billion as of July 16, 2025. Its market cap has increased by 12.26% in one year.
Market Cap
2.34B
Enterprise Value
1.86B
1-Year Change
12.26%
Ranking
Category
Stock Price
$5.39
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.34B, a decrease of -53.95%. That is a compound annual growth rate of -16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 2.29B | -14.06% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.28B |
| Johnson & Johnson | 376.36B |
| AbbVie | 337.58B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 272.14B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 230.58B |
| AstraZeneca | 218.74B |